---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-146929"
form_type: "8-K"
ticker: "MRNA"
cik: "0001682852"
company_name: "Moderna, Inc."
filed_at: "2022-05-11T23:59:59+00:00"
generated_at: "2026-06-25T21:05:33.101523+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Moderna CFO Jorge Gomez departs amid Dentsply Sirona investigation; David Meline returns as CFO

## Summary
- Jorge Gomez terminated as CFO effective May 10, 2022, after former employer Dentsply Sirona disclosed an internal investigation.
- David Meline, previously CFO from June 2020 to July 2021, resumes role effective May 11, 2022.
- Gomez receives 12 months' salary ($700,000) and COBRA coverage; forfeits signing bonus, relocation, bonus, and new hire equity.
- Meline retains annual salary of $700,000, 90% bonus target, and full vesting of 2022 equity awards previously set to forfeit on retirement.

## SEC filing metadata
- accession: 0001193125-22-146929
- form_type: 8-K
- ticker: MRNA
- cik: 0001682852
- company_name: Moderna, Inc.
- filed_at: 2022-05-11T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682852/000119312522146929/0001193125-22-146929-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682852/000119312522146929/d315485d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-146929
- JSON: https://secwatch.observer/filing/0001193125-22-146929.json
- Plain text: https://secwatch.observer/filing/0001193125-22-146929.txt

## Key facts
- Executive change
  David Meline was appointed as Chief Financial Officer at Moderna, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: David Meline, the Company’s recently retired Chief Financial Officer, will continue as Chief Financial Officer, effective May 11, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682852/000119312522146929/0001193125-22-146929-index.htm
- Executive change
  Jorge Gomez departed as Chief Financial Officer at Moderna, Inc..
  - Action: departed
  - Role: Chief Financial Officer
  source text: On May 10, 2022, Jorge Gomez departed, effective immediately, from the role of Chief Financial Officer of Moderna, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682852/000119312522146929/0001193125-22-146929-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.